At Cradle Genomics, our mission is to provide knowledge that helps every pregnancy. We're dedicated to the transformation of non-invasive prenatal testing (NIPT) by offering the most comprehensive fetal genetic analysis and pregnancy health screening solutions at the earliest stages of pregnancy. Cradle Genomics is newly formed with our headquarters based in San Diego. Cradle tests are based on the genetic analysis of fetal cells quickly collected during a first trimester visit with no risk to the mother or developing fetus. We are passionate about improving patient care and enabling global access to the best possible prenatal solutions. For additional information please contact us at info@cradlegenomics.com.
Location: United States, California, San Diego
Employees: 11-50
Total raised: $34.1M
Founded date: 2018
Investors 2
| Date | Name | Website |
| - | Illumina V... | illuminaVe... |
| - | Section 32 | section32.... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 14.07.2021 | Series A | $17M | Illumina V... |
| 17.07.2019 | Series A | $17.1M | - |
Mentions in press and media 8
| Date | Title | Description |
| 06.12.2023 | Cradle Genomics Raises $17.1M Series A Round for Prenatal Testing | - |
| 05.12.2023 | Cradle Genomics Raises $17.1M Series A Round for Prenatal Testing | - |
| 02.12.2023 | Cradle Genomics Raises $17.1M Series A Round for Prenatal Testing | - |
| 01.12.2023 | Cradle Genomics Raises $17.1M Series A Round for Prenatal Testing | - |
| 17.07.2019 | Cradle Genomics Raises $17M Series A | Cradle Genomics, inventors of a novel prenatal testing methodology, today announced the close of a highly successful Series A funding round of $17.1 million with select investors. Illumina Ventures and Section 32 led the investment round wi... |
| 16.07.2019 | Cradle Genomics Raises $17M in Series A Funding | Cradle Genomics, a San Diego, CA-based creator of a novel prenatal testing methodology, closed a $17.1m Series A funding. The round was led by Illumina Ventures and Section 32 with participation from Alexandria Real Estate Equities, Sea Lan... |
| 16.07.2019 | Cradle Genomics Raises $17.1M Series A Round for Prenatal Testing | - |
| - | Cradle Genomics: This Non-Invasive Prenatal Testing Company Has Raised $17.1 Million | Cradle Genomics — the inventors of a novel prenatal testing methodology — announced it closed $17.1 million in Series A funding Cradle Genomics — the inventors of a novel prenatal testing methodology — announced it has closed $17.1 million ... |